NotableResults first posted: Dec 18, 2024v21Show 4 more changesShow less
Primary endpoints: 1 to 3
Secondary endpoints: 9 to 21
Publications: 27 to 28
Study description expanded, about 3 words
MinorTrial status: Active, Not Recruiting to Completed
Primary and study completion dates changed from estimate of May 2024 to Feb 29, 2024
Publications: 26 to 27
v20
MinorPublications: 25 to 26v19
Show 17 earlier versionsHide 17 earlier versions
MinorPublications: 22 to 25v18
MinorPublications: 21 to 22v17
NotablePrimary and study completion dates: May 2020 to May 2024
Secondary endpoints: details revised at 9 of 9 entries
Study description expanded, about 1 word
v16
MinorPublications: 20 to 21v15
MinorPublications: 18 to 20v14
NotablePrimary endpoints: 3 to 1
Secondary endpoints: 5 to 9
Publications: details revised at 2 of 18 entries
Study arms: 2 to 3
v13
Re-verified, no change to tracked fieldsv12
NotablePrimary and study completion dates: May 2014 to May 2020
Secondary endpoints: details revised at 5 of 5 entries
Publications: 15 to 18
Study description expanded, about 1 word
v11
MinorPublications: details revised at 1 of 15 entriesv10
MinorPublications: 12 to 15v9
NotableLead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to Rhode Island Hospitalv8Show 5 more changesShow less
Primary endpoints: 4 to 3
Secondary endpoints: 4 to 5
Collaborators expanded, about 10 words
Publications: 10 to 12
Study description expanded, about 3 words
MinorPublications: details revised at 7 of 10 entriesv7
NotablePrimary and study completion dates: May 2009 to May 2014
Publications: 3 to 10
Study description expanded, about 2 words
v6
Re-verified, no change to tracked fieldsv5
NotablePrimary endpoints revised (4)v4Show 5 more changesShow less
Enrollment target: estimated 162 to confirmed 168
Primary and study completion dates: May 2009
Secondary endpoints revised (4)
Study title shortened, about 7 words
Study arms: 0 to 2
MinorTrial status: Recruiting to Active, Not Recruiting
Site details revised at 2 of 2 sites
v3
Re-verified, no change to tracked fieldsv2
Study First Submitted
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The anterior cruciate ligament (ACL) is one of four strong ligaments connecting the bones of the knee joint. If overstretched, the ACL can tear. Reconstruction of a torn ACL is now a common surgical procedure. The amount of tension applied to the ACL during reconstruction may indirectly affect the possible onset of arthritis over time. The purpose of this study is to determine the effect of initial graft tension set during ACL reconstruction surgery on the progression of knee arthritis over at least a 15-year period.
Trial Details
NCT Number
NCT00434837
Lead Sponsor
Rhode Island Hospital Collaborators: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)